Publications & Posters
Scholary publications
Spinal Muscular Atrophy
March 2024
2024 Muscular Dystrophy Association Clinical and Scientific Conference
Disease Burden in Patients with Spinal Muscular Atrophy (SMA) Treated with Survival Motor Neuron (SMN)-Targeted Therapies: A Targeted Literature Review
Spinal Muscular Atrophy
Apitegromab
March 2024
2024 Muscular Dystrophy Association Clinical and Scientific Conference
Effect of apitegromab on motor function and patient-reported outcomes at 36 months in patients aged 2-21 years with spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
February 2024
Neurology
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3
Cardiometabolic Disease
SRK-439
February 2024
Keystone Symposia: Obesity Causes and Consequences Conference
SRK-439, a Selective Anti-Pro and Latent Myostatin Antibody, Maintains Lean Mass and Enhances Fat Mass Loss in Models of Pharmacologically Induced Weight Loss
Immuno-Oncology
SRK-181
November 2023
Society for Immunotherapy of Cancer 2023
Safety, Efficacy, and Biomarker Results of SRK-181, a Latent TGFβ1 Inhibitor, in Anti‑PD-1 Resistant Metastatic ccRCC Patients
Immuno-Oncology
SRK-181
November 2023
Society for Immunotherapy of Cancer 2023
